Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hailin Tang

Showing results (141-150 of 341) with videos related to

Pageof 35
Sort By:
Cancer Letters|July 16, 2013
Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22Hailin Tang, Yanan Kong, Jiaoli Guo, et al.
Journal of Cancer|December 21, 2016
Pre-treatment serum alkaline phosphatase and lactate dehydrogenase as prognostic factors in triple negative breast cancerBo Chen, Danian Dai, Hailin Tang, et al.
Breast (Edinburgh, Scotland)|March 5, 2017
Development and validation of a nomogram for predicting survival on the base of modified lymph node ratio in breast cancer patientsJiahuai Wen, Yanning Yang, Peng Liu, et al.
Oncology Research|January 30, 2026
Progression on Mechanism and Therapeutic Implications of Neddylation in Lung CancerJiayu Zou, Yajie Lu, Jiaqi Li, et al.
Frontiers in Pharmacology|August 9, 2020
Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast CancerKaiming Zhang, Peng Liu, Hailin Tang, et al.
Journal of Translational Medicine|January 23, 2014
miR-200b as a prognostic factor in breast cancer targets multiple members of RAB familyFeng Ye, Hailin Tang, Qing Liu, et al.
Biosensors & Bioelectronics|May 10, 2024
Simultaneous detection of breast cancer biomarkers circROBO1 and BRCA1 based on a CRISPR-Cas13a/Cas12a systemChengchen Tan, Guoyang Xie, Song Wu, et al.
Chinese Medical Journal|July 9, 2026
Precision targeted therapy and immunotherapy in breast cancer: Advances and clinical frontiersSong Wu, Pangzhou Chen, Wen Zhou, et al.
Journal of Translational Internal Medicine|September 2, 2025
CircPLK1 upregulates ETS1 to confer anthracycline resistance in triple-negative breast cancerDanian Dai, Jinhui Zhang, Yunxian Mo, et al.
Oncology Research|August 1, 2025
Mitochondrial pyruvate dehydrogenase phosphatase metabolism disorder in malignant tumorsYufeng Wang, Huifeng Dang, Qianqian Wang, et al.
Pageof 35

Showing results (141-150 of 341) with videos related to

Sort By:
Pageof 35
Cancer Letters|July 16, 2013
Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22Hailin Tang, Yanan Kong, Jiaoli Guo, et al.
Journal of Cancer|December 21, 2016
Pre-treatment serum alkaline phosphatase and lactate dehydrogenase as prognostic factors in triple negative breast cancerBo Chen, Danian Dai, Hailin Tang, et al.
Breast (Edinburgh, Scotland)|March 5, 2017
Development and validation of a nomogram for predicting survival on the base of modified lymph node ratio in breast cancer patientsJiahuai Wen, Yanning Yang, Peng Liu, et al.
Oncology Research|January 30, 2026
Progression on Mechanism and Therapeutic Implications of Neddylation in Lung CancerJiayu Zou, Yajie Lu, Jiaqi Li, et al.
Frontiers in Pharmacology|August 9, 2020
Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast CancerKaiming Zhang, Peng Liu, Hailin Tang, et al.
Journal of Translational Medicine|January 23, 2014
miR-200b as a prognostic factor in breast cancer targets multiple members of RAB familyFeng Ye, Hailin Tang, Qing Liu, et al.
Biosensors & Bioelectronics|May 10, 2024
Simultaneous detection of breast cancer biomarkers circROBO1 and BRCA1 based on a CRISPR-Cas13a/Cas12a systemChengchen Tan, Guoyang Xie, Song Wu, et al.
Chinese Medical Journal|July 9, 2026
Precision targeted therapy and immunotherapy in breast cancer: Advances and clinical frontiersSong Wu, Pangzhou Chen, Wen Zhou, et al.
Journal of Translational Internal Medicine|September 2, 2025
CircPLK1 upregulates ETS1 to confer anthracycline resistance in triple-negative breast cancerDanian Dai, Jinhui Zhang, Yunxian Mo, et al.
Oncology Research|August 1, 2025
Mitochondrial pyruvate dehydrogenase phosphatase metabolism disorder in malignant tumorsYufeng Wang, Huifeng Dang, Qianqian Wang, et al.
Pageof 35